CANNABICS PHARMACEUTICALS http://www.cannabics.com/investors/ https://twitter.com/cannabics1 http://www.cannabics.com/ http://www.cannabics.com/news/ https://finance.yahoo.com/q?s=cnbx&fr=uh3_finance_web&uhb=uhb2
Cannabics Pharmaceuticals Inc. is a US based company founded in 2012 by Israeli researchers from the fields of molecular biology and cancer.
The Company's scientific focus is on harnessing the proven therapeutic properties of natural Cannabinoids and to create tailored therapies for cancer patients, utilizing advanced HTS technology and personalized bioinformatics tools.
The Company's R&D is based in Israel, where it is fully licensed by The Ministry of Health and involves both scientific and academic research as well as current ongoing medical clinical studies which are registered with the US NIH.
The Company new clinical study examine the effectiveness of Cannabics SR capsules as treatment to improve cancer related CACS (Cachexia and Anorexia) in advanced cancer Patients. While this study is taking place in Israel, it is fully registered with the US NIH under "Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients", identifier NCT02359123 and can be found at: https://clinicaltrials.gov/ct2/show/NCT02359123